======= ANP32B ======= == Gene Information == * **Official Symbol**: ANP32B * **Official Name**: acidic nuclear phosphoprotein 32 family member B * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=10541|10541]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92688|Q92688]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANP32B&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANP32B|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619823|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Multifunctional protein working as a cell cycle progression factor as well as a cell survival factor. Required for the progression from the G1 to the S phase. Anti-apoptotic protein which functions as a caspase-3 inhibitor. Has no phosphatase 2A (PP2A) inhibitor activity (By similarity). Exhibits histone chaperone properties, stimulating core histones to assemble into a nucleosome. {ECO:0000250, ECO:0000269|PubMed:20538007}. |LRR 4| |RNA polymerase binding| |positive regulation of protein export from nucleus| |ventricular system development| |regulation of protein export from nucleus| |positive regulation of nucleocytoplasmic transport| |activation of cysteine-type endopeptidase activity involved in apoptotic process| |roof of mouth development| |regulation of nucleocytoplasmic transport| |nucleosome assembly| |histone binding| |positive regulation of cysteine-type endopeptidase activity involved in apoptotic process| |chromatin assembly| |positive regulation of cysteine-type endopeptidase activity| |positive regulation of intracellular protein transport| |chromatin assembly or disassembly| |nucleosome organization| |positive regulation of endopeptidase activity| |DNA packaging| |positive regulation of peptidase activity| |inner ear development| |protein-DNA complex assembly| |positive regulation of intracellular transport| |regulation of cysteine-type endopeptidase activity involved in apoptotic process| |ear development| |regulation of intracellular protein transport| |regulation of cysteine-type endopeptidase activity| |protein-DNA complex subunit organization| |DNA conformation change| |positive regulation of cellular protein localization| |regulation of intracellular transport| |positive regulation of proteolysis| |regulation of endopeptidase activity| |positive regulation of protein transport| |regulation of peptidase activity| |positive regulation of establishment of protein localization| |vasculature development| |cardiovascular system development| |regulation of cellular protein localization| |sensory organ development| |positive regulation of apoptotic process| |positive regulation of programmed cell death| |positive regulation of cell death| |chromatin organization| |regulation of protein transport| |negative regulation of cell differentiation| |regulation of proteolysis| |regulation of peptide transport| |brain development| |regulation of establishment of protein localization| |positive regulation of hydrolase activity| |head development| |cellular protein-containing complex assembly| |nucleolus| |circulatory system development| |regulation of cellular localization| |negative regulation of developmental process| |central nervous system development| |positive regulation of transport| |regulation of protein localization| |chromosome organization| |regulation of hydrolase activity| |positive regulation of catalytic activity| |regulation of apoptotic process| |protein-containing complex assembly| |regulation of programmed cell death| |positive regulation of cellular protein metabolic process| |regulation of cell death| |positive regulation of protein metabolic process| |positive regulation of molecular function| |regulation of cell differentiation| |protein-containing complex subunit organization| |regulation of transport| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp517|Quercetin 20μM R08 exp517]]|-2.21| |[[:results:exp457|Bisphenol F 50μM R08 exp457]]|-1.86| |[[:results:exp106|UM131593 0.2μM R03 exp106]]|-1.82| |[[:results:exp48|Mubritinib 0.2μM R01 exp48]]|-1.77| |[[:results:exp84|UM0125461 0.74μM R02 exp84]]|-1.77| |[[:results:exp489|Hippuristanol 0.12μM R08 exp489 no dilution day6]]|1.7| |[[:results:exp260|ABT-702 0.1μM R06 exp260]]|2.04| ^Gene^Correlation^ |[[:human genes:a:anp32a|ANP32A]]|0.414| Global Fraction of Cell Lines Where Essential: 0/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/25| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/14| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 12177 * **Expression level (log2 read counts)**: 8.3 {{:chemogenomics:nalm6 dist.png?nolink |}}